Back to results
US 2002/0177603 A1Published application
Tricyclic compounds useful as HIV reverse transcriptase inhibitors
AssigneeBristol-Myers Squibb Pharma Company
InventorsBarry L. Johnson, James D. Rodgers, Qiyan Lin, Anurag S. Srivastava
Life of this patent
Estimating the term…
Abstract
The present invention relates to tricyclic compounds of formula (I): 1 or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Claims18
A compound of formula (I):
- 18
- or a stereoisomeric form or mixture of stereoisomeric forms or a pharmaceutically acceptable salt form thereof, wherein:
- R1 is selected from the group C1-3 alkyl substituted with 0-7 halogen;
- R2 is —(CH2)OCH(CH3)2;
- X is selected from F, Cl, Br, I, and CN;
- Y is selected from F, Cl, Br, I, and CN;
- and
- Z is selected from N and N-oxide.
5 more elements
Dependencies are inferred from the claim text.